TOKYO, May 1, 2026 /PRNewswire/ -- Restore Vision Inc., a clinical-stage biotechnology company advancing gene therapies for retinal disorders, today announced the interim clinical results from its ...

There is cautious optimism that ‘a majority of multilateralists’ may be able to enduringly reshape global alliances ...

Eight Princeton professors were elected to the National Academy of Sciences this year: Cliff Brangwynne, Chris Chang, Maria ...

Mark Milner is studying the switch between healthy and inflammatory microglia cells that could lead to the first treatment to ...

In northern Italy, where there are fewer free-ranging dogs, wolf-dog hybrids are much rarer than in the central and southern ...

The designer often stops by for coffee and sits by the roadside, observing the flow of people and drawing inspiration from daily life. "He is a true creator," Mamadou said. "Every time he walks into ...

New post-hoc analysis of OCT scans on GCIPL and analysis of responders with improvement of 15 or 30-letter on low-contrast visual acuity (LCVA) from the Phase 2 ACUITY trial with Privosegtor, to be ...

Anxiety and depression are prevalent in patients with IPF and are linked to increased breathlessness and lower energy levels.

Understanding why people born blind never develop schizophrenia could transform how we think about and treat one of ...